YD Bio Ltd (YDES) News
Track canonical SquawkNews coverage tagged to YDES, YD Bio Ltd. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 6 indexed stories across 4 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
YDES reports unaudited financial results for six months ended June 30, 2026
YD Bio Limited (YDES) reports unaudited financial results for the six months ended June 30, 2026.
EQUITY | Aug 31, 2026, 10:07 PM UTC
L
YD Bio 1H EPS 9c, above YDES
YD Bio reports 1H EPS of 9c, above the YDES mark.
EARNINGS | Aug 31, 2026, 10:02 PM UTC
L
YD Bio 1H revenue $847,000
TradingView News reports YD Bio 1H revenue of $847,000.
EQUITY | Aug 31, 2026, 10:02 PM UTC
L
YD Bio (YDES) announces peer-reviewed Nutrients publication
YD Bio says a peer-reviewed publication in Nutrients was released, co-authored with physicians from the Taiwan Chronic Disease Healthcare Association and the Future Health Institute.
EQUITY | Aug 25, 2026, 12:02 PM UTC
L
YDES - YD Bio Launches a Physician-Partnership Initiative in Taiwan with the Announcement of Two Nutraceutical Products in Collaboration wit
YDES - YD Bio Launches a Physician-Partnership Initiative in Taiwan with the Announcement of Two Nutraceutical Products in Collaboration with the Taiwan Chronic Disease Healthcare Association and the Future Health Instit
GEOPOLITICS | Aug 11, 2026, 12:02 PM UTC
H
NXTS Plunges 48%
NXTS leads small cap negative movers premarket, down 48% on momentum, followed by WHLR, KIDZ, and others
EQUITY | Jun 23, 2026, 12:22 PM UTC